AFYREN Doubles H1 2026 Revenues as NEOXY Plant Ramp-Up Accelerates…

Event summary

AFYREN NEOXY plant generated €1 million in H1 2026 revenues, doubling FY 2025 figures (€0.5 million).
Production capacity reached 20% of full capacity (16 kt) ahead of June 2026 technical shutdown.
Order book stands at €165 million with internationally recognized certifications obtained.
Full ownership of AFYREN NEOXY biorefinery acquired in March 2026, simplifying financial reporting.

The big picture

AFYREN's progress reflects the broader industrial shift towards sustainable, biobased solutions amid fossil resource constraints. The company's strategic positioning with certified products and a strong order book underscores the growing market demand for low-carbon alternatives. The ramp-up of the NEOXY plant is critical for AFYREN to capitalize on this trend and achieve significant revenue growth.

What we're watching

Production Scaling: Whether AFYREN can sustain the pace of production scaling post-technical shutdown.
Market Demand: How growing concerns over fossil resource availability will impact demand for AFYREN's products.
International Expansion: The pace at which AFYREN can expand into Asia and the Americas.